Ministry Of Health's Advisory On Recall Of Certain Over-The-Counter Medicines
http://www.trinijunglejuice.com/tjjnews/articles/1553/1/Ministry-Of-Healths-Advisory-On-Recall-Of-Certain-Over-The-Counter-Medicines/Page1.html
By TJJ Office Mgr
Published on 10-Jul-10
Port of Spain, July 10, 2010: The Ministry of Health wishes to advise that there has been a
voluntary recall of certain over-the-counter drugs by Johnson and Johnson’s Mc Neil Consumer
Healthcare Products in the United States of America. The risk of serious adverse medical events is
remote. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration
(FDA).
Recalled over-the-counter medications include the following products manufactured in the United
States and distributed in Trinidad & Tobago:
TYLENOL®, Extra Strength EZ TABLET 50 count ABA005 300450422507
TYLENOL®, Extra Strength RAPID RELEASE GELCAP 24 count ACA024 300450488244
BENADRYL® ALLERGY ULTRATAB™ TABLETS 100 count ABA574 312547170338
BENADRYL® ALLERGY ULTRATAB™ TABLETS 100 count ABA567 312547170338
The full list of recalled medications, including lot numbers can be obtained at
www.mcneilproductrecall.com.
This recall was issued on July 08, 2010 as a follow-up to a product recall that McNeil Consumer
Healthcare originally announced on January 15, 2010, which was initiated following consumer
complaints of a musty or moldy odor, which has been linked to the presence of trace amounts of a
chemical called 2,4,6-tribromoanisole (TBA). These lots are being added to the list of recalled
products as a precautionary measure after a continuing internal review determined that some
packaging materials used in the lots had been shipped and stored on the same type of wooden pallet
that was tied to the presence of TBA in earlier recalled lots.
Port of Spain, July 10, 2010: The Ministry of Health wishes to advise that there has been a
voluntary recall of certain over-the-counter drugs by Johnson and Johnson’s Mc Neil Consumer
Healthcare Products in the United States of America. The risk of serious adverse medical events is
remote. This recall is being conducted with....
voluntary recall of certain over-the-counter drugs by Johnson and Johnson’s Mc Neil Consumer
Healthcare Products in the United States of America. The risk of serious adverse medical events is
remote. This recall is being conducted with....
Port of Spain, July 10, 2010: The Ministry of Health wishes to advise that there has been avoluntary recall of certain over-the-counter drugs by Johnson and Johnson’s Mc Neil Consumer
Healthcare Products in the United States of America. The risk of serious adverse medical events is
remote. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration
(FDA).
Recalled over-the-counter medications include the following products manufactured in the United
States and distributed in Trinidad & Tobago:
TYLENOL®, Extra Strength EZ TABLET 50 count ABA005 300450422507
TYLENOL®, Extra Strength RAPID RELEASE GELCAP 24 count ACA024 300450488244
BENADRYL® ALLERGY ULTRATAB™ TABLETS 100 count ABA574 312547170338
BENADRYL® ALLERGY ULTRATAB™ TABLETS 100 count ABA567 312547170338
The full list of recalled medications, including lot numbers can be obtained at
www.mcneilproductrecall.com.
This recall was issued on July 08, 2010 as a follow-up to a product recall that McNeil Consumer
Healthcare originally announced on January 15, 2010, which was initiated following consumer
complaints of a musty or moldy odor, which has been linked to the presence of trace amounts of a
chemical called 2,4,6-tribromoanisole (TBA). These lots are being added to the list of recalled
products as a precautionary measure after a continuing internal review determined that some
packaging materials used in the lots had been shipped and stored on the same type of wooden pallet
that was tied to the presence of TBA in earlier recalled lots.